Evaluation of safety and immunogenicity of live attenuated oral Rotavin-M1 vaccine for diarrhea prevention in Vietnamese children

PROJECT OVERVIEW

Project: "Evaluation of safety and immunogenicity of live attenuated oral Rotavin-M1 vaccine for diarrhea prevention in Vietnamese children" (code: KC.10.33/06-10) was implemented from 2009 to 2010 at POLYVAC.

Research Details
  • TOPIC NAME Evaluation of safety and immunogenicity of live attenuated oral Rotavin-M1 vaccine for diarrhea prevention in Vietnamese children
  • Name of the principal Assoc. Prof. Dr. Lê Thị Luân
  • Classification State-level scientific research project
  • Execution time 2009-2010

Project/Topic Results

Products and Testing
  • 5,000 doses of Rotavin-M1 Vaccine lot 03R2009
  • Quality control of Rotavin-M1 vaccine lot 03R2009
Clinical Research
  • Evaluating safety and immunogenicity of Rotavin-M1 produced by POLYVAC in Phase I, II, and III
  • Determining dosage and usage schedules for each target group
  • Comparing safety and immune response of Rotavin-M1 and Rotarix (Belgium)
Scientific publication and training
  • 04 papers published in the Journal of Preventive Medicine
  • 01 paper published in an international Rota conference
  • 02 PhDs